Citation: Ab. Alfieri et Cj. Gardner, EFFECTS OF GR203040, AN NK1 ANTAGONIST, ON RADIATION-INDUCED AND CISPLATIN-INDUCED TISSUE-DAMAGE IN THE FERRET, General pharmacology, 31(5), 1998, pp. 741-746
Citation: Lx. Cubeddu et al., URINARY CGMP EXCRETION, EXERCISE TRAINING AND CARDIAC REHABILITATION, Naunyn-Schmiedeberg's archives of pharmacology, 358(1), 1998, pp. 225-225
Citation: Ab. Alfieri et L. Cubeddu, GR205171, A NK1 RECEPTORS ANTAGONIST, REDUCES CISPLATIN-INDUCED NEPHROTOXICITY IN THE RAT, Naunyn-Schmiedeberg's archives of pharmacology, 358(1), 1998, pp. 412-412
Citation: Ab. Alfieri et al., DEXAMETHASONE ENHANCES GR205171 INHIBITION OF CYTOTOXIC-INDUCED PLASMA-PROTEIN EXTRAVASATION IN FERRETS, British Journal of Pharmacology, 118, 1996, pp. 151-151
Citation: Ab. Alfieri et Cj. Gardner, AN ANTAGONIST OF TACHYKININ NK1 RECEPTORS INHIBITS CYTOTOXIC-INDUCED PLASMA-PROTEIN EXTRAVASATION IN THE FERRET, British Journal of Pharmacology, 116, 1995, pp. 251-251
Citation: Ab. Alfieri et Lx. Cubeddu, COMPARATIVE EFFICACY OF A SINGLE ORAL DOSE OF ONDANSETRON AND OF BUSPIRONE AGAINST CISPLATIN-INDUCED EMESIS IN CANCER-PATIENTS, British Journal of Cancer, 72(4), 1995, pp. 1013-1015
Citation: Ab. Alfieri et Lx. Cubeddu, TREATMENT WITH PARA-CHLOROPHENYLALANINE ANTAGONIZES THE EMETIC RESPONSE AND THE SEROTONIN-RELEASING ACTIONS OF CISPLATIN IN CANCER-PATIENTS, British Journal of Cancer, 71(3), 1995, pp. 629-632
Citation: Ab. Alfieri et Lx. Cubeddu, EFFECTS OF INHIBITION OF SEROTONIN SYNTHESIS ON 5-HYDROXYINDOLEACETICACID EXCRETION, IN HEALTHY-SUBJECTS, Journal of clinical pharmacology, 34(2), 1994, pp. 153-157